US2015344412A1PendingUtilityA1

Novel phenicol antibacterials

41
Assignee: ZOETIS SERVICES LLCPriority: Oct 17, 2011Filed: Aug 7, 2015Published: Dec 3, 2015
Est. expiryOct 17, 2031(~5.3 yrs left)· nominal 20-yr term from priority
A61P 31/04C07D 205/04C07C 233/47C07C 2601/02C07C 311/06C07D 413/10C07D 263/04C07C 311/05C07D 207/08C07D 207/09C07C 275/18C07C 233/40C07C 275/24C07C 233/18C07C 2101/02
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical compositions containing these novel compounds, and methods for the preparation of these compounds.

Claims

exact text as granted — not AI-modified
1 . A compound of formula I 
       
         
           
           
               
               
           
         
       
       or pharmaceutical acceptable salts thereof wherein
 Aryl moiety is phenyl or naphthyl, optionally substituted with one to three R 6 ; 
 R 1  is 
 a. H, 
 b. —C 1-8 alkyl, optionally substituted with one or more OH, —SH, —CN, —NO 2 , —NHR 5 , —NC 1-4 alkylR 5 , —OC 1-4 alkyl, —SC 1-4 alkyl, —S(C═O)C 1-4 alkyl, —C(═O)NR 5 R 5 , —SO 2 NR 5 , —SO 2 R 5 , or —C 3-6 cycloalkyl, 
 c. —C 3-8 cycloalkyl, optionally substituted with one to three R 6 , 
 d. —SO 2 R 5 , 
 e. —C(═O)R 5 , or 
 f. 4 to 6 membered heterocyclic ring moiety optionally contains one, two or three atoms selected from the group consisting from N, S and O, wherein the heterocyclic ring is optionally substituted with one to three R 6 ; 
 R 2  is 
 a. —C 1-8 alkyl, optionally substituted with one or more OH, —SH, —CN, —NO 2 , —NC 1-4 alkylR 5 , —OC 1-4 alkyl, —SC 1-4 alkyl, —S(C═O)C 1-4 alkyl, —C(═O)NR 5 R 5 , —SO 2 NR 5 , —SO 2 R 5 , or —C 3-6 cycloalkyl, 
 b. —C 3-8 cycloalkyl, optionally substituted with one to three R 6 , 
 c. —S(═O 2 )R 5 , 
 d. —C(═O)R 5 , or 
 e. 4 to 6 membered heterocyclic ring moiety optionally contains one, two or three atoms selected from the group consisting from N, S and O, wherein the heterocyclic ring is optionally substituted with one to three R 6 ; 
 R 3  and R 4  are independently 
 a. —H, 
 b. —C 1-8 alkyl optionally substituted with OH, —SH, halo, —CN, —NO 2 , NH 2 , —NHR 5 , —NHR 5 —OC 1-4 alkyl, —SC 1-4 alkyl, —S(C═O)C 1-4 alkyl, —C(═O)NR 5 R 5 , —SO 2 NR 5 , or —SO 2 R 5 , 
 c. —C 3-8 cycloalkyl, optionally substituted with one to three R 6 , 
 d. —C(═O)C 1-8 alkyl wherein alkyl is optionally substituted with —S(═O 2 )R 5 , —SO 2 NR 5 , or —C(═O)R 5 , 
 e. 4 to 6 membered heterocyclic ring moiety optionally contains one, two or three atoms selected from the group consisting from N, S and O, wherein the heterocyclic ring is optionally substituted with one to three R 6 , 
 f. R 3  and R 4  taken together form a C 3-8 cycloalkyl, optionally substituted with one to three R 6 ; or 
 g. R 3  and R 4  taken together with one or two additional atoms selected from the group consisting from N, S and O form a 4 to 6 membered heterocyclic ring moiety, wherein the heterocyclic ring is optionally substituted with one to three R 6 ; or 
 R 1  and R 2 , R 1  and R 3 , or R 2  and R 3 , taken together form a 4 to 6 membered heterocyclic ring moiety optionally contains one or two additional atoms selected from the group consisting from N, S and O, wherein the heterocyclic ring is optionally substituted with one to three R 6 ; 
 at each occurrence, R 5  is hydrogen, or C 1-6 alkyl wherein said C 1-6 alkyl is optionally substituted with one, two or three R 6 ; 
 at each occurrence, R 6  is OH, halo, —CN, —NO 2 , —C 3-6 cycloalkyl, —NH 2 , —NHC 1-4 alkyl, —N(C 1-4 alkyl) 2 , —OC 1-4 alkyl, —SH, —SC 1-4 alkyl, —S(C═O)C 1-4 alkyl, —SONC 1-4 alkyl, —C(═O)C 1-4  alkyl, —C(═O)NH 2 , —C(═O)NHC 1-4 alkyl, —C(═O)N(C 1-4 alkyl) 2 , —NC(═O)NH 2 , —NC(═O)NHC 1-4 alkyl, or NC(═O)N(C 1-4 alkyl) 2 ; 
 W is —H, —PO(OH) 2 , —CH 2 PO(OH) 2 , —C(═O)C 1-4 alkyl, or —CH 2 OC(═O)C 1-4 alkyl, wherein C 1-4 alkyl is optionally substituted with —OCO 2 H, —OCO 2 C 1-4 alkyl, or —OC(═O)NHC 1-4 alkyl; 
 X and Y are independently halo, C 1-4 alkyl, CF 3 , —NH 2 , —CN, or N 3 ; and with proviso that when one of R 3  and R 4  is —C 1-8 alkyl; then R 2  may be H. 
 
     
     
         2 . A compound of  claim 1  which is a compound of formula IA 
       
         
           
           
               
               
           
         
       
     
     
         3 . A compound of  claim 1  which is a compound of formula IB 
       
         
           
           
               
               
           
         
       
     
     
         4 . A compound of  claim 2  wherein W is H. 
     
     
         5 . A compound of  claim 4  wherein R 2  is C 1-8 alkyl. 
     
     
         6 . A compound of  claim 5  wherein said alkyl is substituted with —SO 2 R 5 , —C 3-6 cycloalkyl, —NHC 1-4 alkyl, or —N(C 1-4 alkyl) 2 . 
     
     
         7 . A compound of  claim 4  wherein R 2  is —SO 2 R 5 . 
     
     
         8 . A compound of  claim 4  wherein R 3  and R 4  are independently H. 
     
     
         9 . A compound of  claim 4  wherein R 3  and R 4  taken together form a C 3-9 cycloalkyl. 
     
     
         10 . A compound of  claim 4  wherein R 3  and R 4  taken together with one or two additional atoms selected from the group consisting from N, S and O form a 4 to 6 membered heterocyclic ring moiety. 
     
     
         11 . A compound of  claim 10  wherein R 3  and R 4  taken together form a 4 to 6 membered heterocyclic ring moiety which contains a group selected from group consisting of —S—, —S(═O)—, —S(═O 2 )—, —NH—, and —NR 5 —. 
     
     
         12 . A compound of  claim 4  wherein R 1  and R 2  taken together form a 4 to 6 membered heterocyclic ring moiety optionally contains one or two additional atoms selected from the group consisting from N, S and O. 
     
     
         13 . A compound of  claim 12  wherein the heterocyclic ring moiety optionally substituted with one or two R 6 . 
     
     
         14 . A compound of  claim 12  wherein R 1  and R 2  taken together with the nitrogen to which they are attached form a 4 to 6 membered heterocyclic ring moiety which further contains a sulfur atom. 
     
     
         15 . A compound of  claim 4  wherein R 2  and R 3  taken together form a 4 to 6 membered heterocyclic ring moiety optionally contains one or two additional atoms selected from the group consisting from N, S and O. 
     
     
         16 . A compound of  claim 15  wherein R 2  and R 3  taken together with the nitrogen to which they attach form a 4 to 6 membered heterocyclic ring moiety which further contains a sulfur atom. 
     
     
         17 . A compound of  claim 16  wherein said heterocyclic ring moiety is optionally substituted with R 6 . 
     
     
         18 . A compound of  claim 4  wherein X and Y are chloride. 
     
     
         19 . A compound of  claim 4  wherein R 3  and R 4  are independently H or —C 1-8 alkyl. 
     
     
         20 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.